Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings

Chinese Medical Journal

Volumn 122, Issue 3, 2009, Pages 301-306

  Jin, Hui ^a   Xu, Xiao Min ^b   Mi, Zu Huang ^c   Mou, Yi ^d   Liu, Pei ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Department of Microbiology Laboratory ^*  (China)

^c Wuxi Clone Gen Tech Institute   (China)

^d WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

Acinetobacter baumannii; Amplified fragment length polymorphism fingerprinting; Drug resistance gene typing; Pulsed field gel electrophoresis

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; SULFAMETHOXAZOLE; SULPERAZON;

ACINETOBACTER BAUMANNII; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIUM IDENTIFICATION; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDEMIC; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL INFECTION; HUMAN; INTERMETHOD COMPARISON; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 62749164742     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.03.012     Document Type: Article

References (24)

1. Mammeri H, Poirel L, Mangeney N, Nordmann P. Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother 2003; 47: 1536-1542.
2. Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology and antimicrobial susceptibility. Clin Infect Dis 2000; 31: 690-697.
3. Koeleman JG, Parlevliet GA, Dijkshoom L, Savelkoul PH, Vandenbroucke-Grauls CM. Nosocomial outbreak of multi-resistant Acinetobacter baumannii on a surgical ward: epidemiology and risk factors for acquisition. J Hosp Infect 1997; 37: 113-123.
4. Vahaboglu H, Ozturk R, Aygun G, Coskunkan F, Yaman A, Kaygusuz A, et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicro Agents Chemother 1997; 41: 2265-2269.
5. Marilyn CR. Multidrug-resistant genes are associated with an 86-kb island in Acinetobacter baumannii. Trends Microbiol 2006; 14: 375-378.
6. Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, Bart A, et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 2005; 43: 4862-4864.
7. Wu TL, Chia JH, Su LH, Kuo AJ, Chu C, Chiu CH. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol 2003; 41: 4836-4838.
8. Cousin SJ, Whittington WL, Roberts MC. Acquired macrolide resistance genes in pathogenic Neisseria spp. isolated between 1940 and 1987. Antimicrob Agents Chemother 2003; 47: 3877-3880.
9. Erika MC, Monique MG, Tang YW. Comparsion of pulsed-field gel electrophoresis and amplified fragment-length polymorphism for epidemiological investigations of common nosocomial pathogens. Infect Control Hosp Epidemiol 2001; 22: 550-554.
10. Tenover FC, Arbeit RD, Goering RV. The Molecular Typing Working Group of the Society for Healthcare Epidemiology of America How to select and interpret molecular strain typing methods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Infect Control Hosp Epidemiol 1997; 18: 426-439.
11. Afzal-Shah M, Woodford N, Livermore DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicro Agents Chemother 2001; 45: 583-588.
12. Chu YW, Afkal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, et al. IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicro Agents Chemother 2001; 45: 710-714.
13. Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 3198-3202.
14. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter spp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 2006; 50: 4114-4123.
15. Jeon BC, Jeong SH, Bae IK, Kwon SB, Lee K, Young D, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea. J Clin Microbiol 2005; 43: 2241-2245.
16. Landman D, Quale JM, Mayorga D, Adedeji A, Vangala K, Ravishankar J, et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY. Arch, Intern Med 2002; 162: 1515-1520.
17. Lee K, Yong D, Yum JH, Lim YS, Bolmstrom A, Qwarnstrom A, et al. Evaluation of Etest MBL for detection of blaIMP-1 and blaVIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2005; 43: 942-944.
18. Mammeri H, Poirel L, Mangeney N, Nordmann P. Chromosomal integration of a cephalosporinase gene from, Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother 2003; 47: 1536-1542.
19. Nass T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, Bernet C, et al. French nosocomial infection early warning investigation and surveillance network. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006; 12: 1214-1222.
20. Turton JF, Kaufmann ME, Glover J, Coelho JM, Warner M, Pike R, et al. Detection and typing of integrons in epidemic strains of Acinetobacter baumannii found in the United Kingdom. J Clin Microbiol 2005; 43: 3074-3082.
21. Noppe-Leclercq I, Wallet F, Haentjens S, Courcol R, Simonet M. DCR detection of aminoglycoside resistance genes: a rapid molecular typing method for Acinetobacter baumannii. Res Microbiol 1999; 150: 317-322.
22. Poirel L, Cabanne L, Vahaboglu H, Nordmann P. Genetic environment and expression of the extended-spectrum beta-lactamase blaPER-1 gene in gram-negative bacteria. Antimicrob Agents Chemother 2005; 49: 1708-1713.
23. Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003; 41: 3542-3547.
24. Agodi A, Zarrilli R, Barchitta M, Anzaldi A, Di Popolo A, Mattaliano A, et al. Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital. Clin Microbiol Infect 2006; 12: 241-247.